Prescription Drugs

State (Maine)
Maine 132nd Legislature

An Act to Clarify the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental Illness [SB-1100] [Healthcare ] [Mental Health ] [Pharmaceuticals ]
An Act to Clarify the Requirements for Accessing Nonformulary Drugs and Drugs Used to Treat Serious Mental Illness

  

Sponsored by: Sen. Donna Bailey On Motion By Senator Rotundo Of Androscoggin Placed On The Special Appropriations Table Pending Enactment In Concurrence. on 06/02/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Ensure That Rebates from Prescription Drug Manufacturers Are Passed on to Patients at Pharmacies [HB-1053] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ]
An Act to Ensure That Rebates from Prescription Drug Manufacturers Are Passed on to Patients at Pharmacies

  

Sponsored by: Sen. Nicole Grohoski Pursuant To Joint Rule 310.3 Placed In Legislative Files (dead) on 04/17/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program [SB-1018] [Healthcare ] [Pharmaceuticals ] [Public Health ]
An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program

  

Sponsored by: Sen. Matthea Larsen Daughtry Passed To Be Enacted, In Concurrence. on 06/16/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Idaho)
Idaho 2025 Regular Session

Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers. [HB-385] [Pharmaceuticals ] [Healthcare ] [Consumer Protection ]
PRESCRIPTION DRUGS -- Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers.

  

Sponsored by: Rep. Reported Printed And Referred To Health & Welfare on 03/10/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Permit the Dispensing of Ivermectin Pursuant to a Standing Order upon Request for COVID-19, Flu and Cancer Patients [SB-890] [Healthcare ] [Pharmaceuticals ] [Public Health ]
An Act to Permit the Dispensing of Ivermectin Pursuant to a Standing Order upon Request for COVID-19, Flu and Cancer Patients

  

Sponsored by: Sen. Jeffrey Timberlake Pursuant To Joint Rule 310.3 Placed In Legislative Files (dead) on 05/21/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Amend the Laws Governing the Controlled Substances Prescription Monitoring Program [HB-765] [Healthcare ] [Pharmaceuticals ] [Public Health ] [Overdose Prevention ] [Data Privacy ] [Law Enforcement ] [Crime ] [Criminal Justice ]
An Act to Amend the Laws Governing the Controlled Substances Prescription Monitoring Program

  

Sponsored by: Rep. Michele Meyer Passed To Be Enacted, In Concurrence. on 04/17/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing [SB-697] [Healthcare ] [Pharmaceuticals ] [Medicare and Medicaid ] [Public Health ] [Budget and Spending ]
An Act to Direct the Maine Prescription Drug Affordability Board to Assess Strategies to Reduce Prescription Drug Costs and to Take Steps to Implement Reference-based Pricing

  

Sponsored by: Sen. Donna Bailey On Motion By Senator Rotundo Of Androscoggin Placed On The Special Appropriations Table Pending Enactment In Concurrence on 06/02/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives [HB-538] [Reproductive Rights ] [Healthcare ] [Pharmaceuticals ] [Public Health ]
An Act to Amend Maine's Prescription Drug Labeling Law by Allowing the Removal of the Name of a Prescriber of Mifepristone, Misoprostol and Their Generic Alternatives

  

Sponsored by: Rep. Ryan Fecteau Passed To Be Enacted, In Concurrence. on 05/27/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-seventh Legislature - First Regular Session (2025)

Prescription drugs; price limits [SB-1403] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ]
Prescription drugs; price limits

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/04/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-seventh Legislature - First Regular Session (2025)

Essential drugs; price increases; limits. [SB-1402] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ] [Inflation ]
Essential drugs; price increases; limits.

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/04/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [SB-1509] [Healthcare ] [Pharmaceuticals ] [Insurance ]
Requires the Legislative Reference Bureau to conduct a study on best practices for the regulation of pharmacy benefit managers and reduction in prescription drug costs for health insurance plan beneficiaries. Requires a report to the Legislature. Effective 12/31/2050. (HD1)

  

Sponsored by: Sen. Ronald Kouchi The Committee(s) On Cpc Recommend(s) That The Measure Be Deferred. on 03/19/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Health. [HB-712] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ] [Public Health ]
Prohibits drug manufacturers from denying, restricting, or prohibiting the acquisition, shipping, or delivery of a 340B drug to pharmacies contracted with 340B covered entities under the federal 340B Drug Pricing Program. Authorizes 340B covered entities and the Attorney General to bring a civil action for enforcement within four years of a violation. Beginning 7/1/2026, requires each 340B covered entity in the State to report certain information annually to the hospital trade association operating in the State and requires the hospital trade association (continued...)

  

Sponsored by: Rep. Gregg Takayama Act 143, On 05/30/2025 (gov. Msg. No. 1243). on 05/30/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Health. [SB-480] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ] [Public Health ]
Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.

  

Sponsored by: Sen. Joy San Buenaventura The Committee On Hhs Deferred The Measure. on 02/10/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act to Allow Retail Pharmacies to Operate Remote Dispensing Sites in Rural Areas [SB-239] [Healthcare ] [Public Health ] [Pharmaceuticals ]
An Act to Allow Retail Pharmacies to Operate Remote Dispensing Sites in Rural Areas

  

Sponsored by: Sen. Bradlee Farrin Passed To Be Enacted, In Concurrence. on 05/27/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [HB-216] [Healthcare ] [Insurance ] [Pharmaceuticals ] [Consumer Protection ]
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

  

Sponsored by: Rep. Gregg Takayama Referred To Hlt, Cpc, Fin, Referral Sheet 1 on 01/21/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Hawaii)
Hawaii 2025 Regular Session

Relating To Prescription Drugs. [SB-226] [Healthcare ] [Insurance ] [Pharmaceuticals ] [Consumer Protection ]
Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

  

Sponsored by: Sen. Lynn Decoite Referred To Hhs, Cpn. on 01/17/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 132nd Legislature

An Act Regarding Reimbursements by Health Insurance Carriers or Pharmacy Benefits Managers to Pharmacies [HB-180] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ]
An Act Regarding Reimbursements by Health Insurance Carriers or Pharmacy Benefits Managers to Pharmacies

  

Sponsored by: Rep. Kristi Mathieson Passed To Be Enacted, In Concurrence. on 06/12/2025

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Maine)
Maine 131st Legislature

An Act to Provide Greater Transparency About the Cost of Insulin and to Promote the Availability of Low-cost Insulin in the State [SB-2282] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ] [Public Health ]
An Act to Provide Greater Transparency About the Cost of Insulin and to Promote the Availability of Low-cost Insulin in the State

  

Sponsored by: No sponsors Passed To Be Enacted, In Concurrence. on 04/03/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Idaho)
Idaho 2024 Regular Session

Adds to existing law to establish equitable billing practices for 340B drugs and covered entities. [HB-671] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ]
PRESCRIPTION DRUGS -- Adds to existing law to establish equitable billing practices for 340B drugs and covered entities.

  

Sponsored by: Rep. Reported Printed And Referred To Health & Welfare on 02/28/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Arizona)
Arizona Fifty-sixth Legislature - Second Regular Session (2024)

Prescription drugs; price limits [SB-1532] [Healthcare ] [Pharmaceuticals ] [Consumer Protection ]
Prescription drugs; price limits

  

Sponsored by: Sen. Lela Alston Senate Read Second Time on 02/06/2024

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0